Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CASR | P41180 | 1/20 | 0.33 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.31 |
| ▸ | SCN4A | P35499 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23627366 | 0.88 | MAOA (0.33) | MAOAMAOBKDM4EALDH1A1GLA | |
| SCHEMBL9918889 | 0.78 | MAOA (0.35) | MAOAMAOBKDM4EALDH1A1GLA | |
| SCHEMBL24337163 | 0.77 | MAOA (0.39) | MAOAMAOBKDM4EALDH1A1GLA | |
| SCHEMBL21775772 | 0.76 | HTR1A (0.40) | KDM4EALDH1A1GAASCN4AL3MBTL1 | |
| SCHEMBL21775788 | 0.75 | ALDH1A1 (0.33) | KDM4EALDH1A1GAASCN4A | |
| SCHEMBL21775754 | 0.73 | ALDH1A1 (0.43) | ALDH1A1GLAGAATSHR | |
| SCHEMBL15747178 | 0.70 | SCN4A (0.47) | MAOAMAOBKDM4EALDH1A1TSHR | |
| SCHEMBL21775766 | 0.70 | SCN8A (0.39) | KDM4EALDH1A1GAAL3MBTL1 | |
| SCHEMBL21774682 | 0.69 | PPARA (0.32) | GAA | |
| SCHEMBL21775757 | 0.69 | CNR1 (0.42) | KDM4EALDH1A1GAATSHRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210206901-A1 | COMPOUND, COMPOSITION CONTAINING THE SAME, METHOD FOR FORMING RESIST PATTERN AND METHOD FOR FORMING INSULATING FILM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-07-08 | — | — | US | disclosed |
| WO-2020040161-A1 | COMPOUND, COMPOSITION CONTAINING SAME, METHOD FOR FORMING RESIST PATTERN, AND METHOD FOR FORMING INSULATING FILM | 三菱瓦斯化学株式会社 | 2020-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210206901-A1 | COMPOUND, COMPOSITION CONTAINING THE SAME, METHOD FOR FORMING RESIST PATTERN AND METHOD FOR FORMING INSULATING FILM | BMI1, PRDM9, CTCF | MAOA 461/4885MAOB 176/4885KDM4E 584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.